| Biotechnology Industry | Healthcare Sector | Mr. Xiangyun Qian CEO | XSHE Exchange | CNE1000058W2 ISIN |
| CN Country | 524 Employees | 29 May 2026 Last Dividend | - Last Split | - IPO Date |
Suzhou Fushilai Pharmaceutical Co., Ltd., founded in 1997 and based in Changshu, China, is a prominent biopharmaceutical company. It specializes in the manufacture and sale of biopharmaceutical products within the Chinese market, offering a variety of products majorly utilized in medicines, dietary supplements, cosmetics, and various other fields. The company plays a significant role in both local and international markets, exporting its products to regions including Europe, America, Southeast Asia, among other countries. The focus on quality manufacturing and a broad product range underscores its commitment to addressing diverse health and wellness needs globally.
The company's product lineup includes: